×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CDNA – caredx, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CDNA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/15
10:47 am
cdna
After Plunging -11.97% in 4 Weeks, Here's Why the Trend Might Reverse for CareDx (CDNA) [Yahoo! Finance]
Low
Report
After Plunging -11.97% in 4 Weeks, Here's Why the Trend Might Reverse for CareDx (CDNA) [Yahoo! Finance]
11/14
11:31 am
cdna
Are Medical Stocks Lagging CareDx (CDNA) This Year? [Yahoo! Finance]
Low
Report
Are Medical Stocks Lagging CareDx (CDNA) This Year? [Yahoo! Finance]
11/12
07:05 am
cdna
CareDx to Participate in Upcoming Investor Conferences
Low
Report
CareDx to Participate in Upcoming Investor Conferences
11/7
09:17 am
cdna
Accelerated Testing Volume Lifted CareDx (CDNA) in Q3 [Yahoo! Finance]
Low
Report
Accelerated Testing Volume Lifted CareDx (CDNA) in Q3 [Yahoo! Finance]
11/6
06:42 am
cdna
CareDx Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Low
Report
CareDx Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/5
01:49 pm
cdna
CareDx, Inc (NASDAQ: CDNA) had its price target lowered by analysts at BTIG Research from $40.00 to $35.00. They now have a "buy" rating on the stock.
Low
Report
CareDx, Inc (NASDAQ: CDNA) had its price target lowered by analysts at BTIG Research from $40.00 to $35.00. They now have a "buy" rating on the stock.
11/5
02:27 am
cdna
CareDx Inc (CDNA) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic ... [Yahoo! Finance]
Low
Report
CareDx Inc (CDNA) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic ... [Yahoo! Finance]
11/4
04:05 pm
cdna
CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance
Medium
Report
CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/18
05:12 pm
cdna
Form 144 CareDx, Inc. Filed by: Novack Jeffrey Adam
Low
Report
Form 144 CareDx, Inc. Filed by: Novack Jeffrey Adam
11/14
05:14 pm
cdna
Form SC 13G/A CareDx, Inc. Filed by: Bellevue Asset Management (UK) Ltd.
Low
Report
Form SC 13G/A CareDx, Inc. Filed by: Bellevue Asset Management (UK) Ltd.
11/8
04:38 pm
cdna
Form 4 CareDx, Inc. For: Nov 06 Filed by: Novack Jeffrey Adam
Low
Report
Form 4 CareDx, Inc. For: Nov 06 Filed by: Novack Jeffrey Adam
11/8
02:34 pm
cdna
Form SC 13G/A CareDx, Inc. Filed by: Nikko Asset Management Americas, Inc.
Low
Report
Form SC 13G/A CareDx, Inc. Filed by: Nikko Asset Management Americas, Inc.
11/5
04:43 pm
cdna
Form 4 CareDx, Inc. For: Nov 01 Filed by: Bickerstaff George
Medium
Report
Form 4 CareDx, Inc. For: Nov 01 Filed by: Bickerstaff George
11/5
04:34 pm
cdna
Form 4 CareDx, Inc. For: Nov 01 Filed by: Novack Jeffrey Adam
Medium
Report
Form 4 CareDx, Inc. For: Nov 01 Filed by: Novack Jeffrey Adam
11/5
04:32 pm
cdna
Form 4 CareDx, Inc. For: Nov 01 Filed by: Jain Abhishek
Medium
Report
Form 4 CareDx, Inc. For: Nov 01 Filed by: Jain Abhishek
11/5
06:07 am
cdna
Form SC 13G/A CareDx, Inc. Filed by: Sumitomo Mitsui Trust Group, Inc.
Low
Report
Form SC 13G/A CareDx, Inc. Filed by: Sumitomo Mitsui Trust Group, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating.
17.3%
4/6 CareDx Supports Launch of International COVID-19 Transplant Registry (C19TxR) 15.5%
5/8 Q1/2019 3/31/2019 EPS 0.050 ZacksConsensus -0.150 ActVsEst 0.200 - Beat 12.9%
1/13 Form 8-K CareDx, Inc. For: Jan 13 10.3%
4/14 CareDx Introduces AlloCell: Cell Therapy Surveillance 7.6%
9/11 CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7.4%
10/2 Form 4 CareDx, Inc. For: Oct 01 Filed by: COURNOYER CHRISTINE 7.4%
5/1 CareDx Inc (NASDAQ: CDNA) had its price target lowered by analysts at Piper Sandler from $59.00 to $54.00. They now have an "overweight" rating on the stock. 7.4%
3/20 New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy 7.0%
6/11 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 6.6%
4/6 CareDx Supports Launch of International COVID-19 Transplant Registry (C19TxR) 15.5%
5/8 Q1/2019 3/31/2019 EPS 0.050 ZacksConsensus -0.150 ActVsEst 0.200 - Beat 12.9%
1/13 Form 8-K CareDx, Inc. For: Jan 13 10.3%
4/14 CareDx Introduces AlloCell: Cell Therapy Surveillance 7.6%
9/11 CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7.4%
10/2 Form 4 CareDx, Inc. For: Oct 01 Filed by: COURNOYER CHRISTINE 7.4%
5/1 CareDx Inc (NASDAQ: CDNA) had its price target lowered by analysts at Piper Sandler from $59.00 to $54.00. They now have an "overweight" rating on the stock. 7.4%
3/20 New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy 7.0%
6/11 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 6.6%
TOP News Decliners
3/16
Form 4 CareDx, Inc. For: Mar 16 Filed by: Maag Peter
-19.3%
7/15 Form 4/A CareDx, Inc. For: Jun 17 Filed by: Goldberg Michael -12.9%
8/3 INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. -12.4%
10/31 Form 8-K CareDx, Inc. For: Oct 31 -12.0%
11/4 CareDx Advances Patient Care with AlloSure 3.0 -10.7%
3/12 CareDx Joins National Kidney Foundation on World Kidney Day to Support Kidney Transplant Community -10.2%
6/21 Form 4 CareDx, Inc. For: Jun 20 Filed by: Bell Michael Brian -10.0%
8/8 Form 4 CareDx, Inc. For: Aug 06 Filed by: Seeto Reginald -9.0%
7/16 Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) -8.4%
10/16 CareDx Inc (NASDAQ: CDNA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -8.3%
7/15 Form 4/A CareDx, Inc. For: Jun 17 Filed by: Goldberg Michael -12.9%
8/3 INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. -12.4%
10/31 Form 8-K CareDx, Inc. For: Oct 31 -12.0%
11/4 CareDx Advances Patient Care with AlloSure 3.0 -10.7%
3/12 CareDx Joins National Kidney Foundation on World Kidney Day to Support Kidney Transplant Community -10.2%
6/21 Form 4 CareDx, Inc. For: Jun 20 Filed by: Bell Michael Brian -10.0%
8/8 Form 4 CareDx, Inc. For: Aug 06 Filed by: Seeto Reginald -9.0%
7/16 Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) -8.4%
10/16 CareDx Inc (NASDAQ: CDNA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -8.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: